Targeting the PI3K and Ras Signal Transduction Pathways in a Murine Model of Osteolytic Breast Cancer Metastasis
atmire.migration.oldid | 658 | |
dc.contributor.advisor | Jirik, Frank | |
dc.contributor.author | Bosma, Nicholas | |
dc.date.accessioned | 2013-01-25T17:23:26Z | |
dc.date.available | 2015-07-31T07:00:47Z | |
dc.date.issued | 2013-01-25 | |
dc.date.submitted | 2013 | en |
dc.description.abstract | Bone metastasis frequently occurs in patients with advanced breast cancer, and leads to widespread bone destruction. Aberrant activation of the PI3K and Ras-MAPK pathways are consistently observed in high-grade metastatic breast cancers, making these pathways attractive targets for therapeutic intervention. Complex signal crosstalk between these pathways is implicated in cancer cell perpetuation; therefore, dual inhibition should theoretically provide maximal targeting. The PI3K and MEK inhibitors, PX866 and AZD6244 were employed to investigate the therapeutic potential in an in vivo model of MDA-MB-231-EGFP/Luc2 human breast cancer osteolytic metastases. PI3K inhibition did not directly affect bone-colonized cancer cells, however, it demonstrated an attenuation of bone loss, whereas MEK inhibition resulted in a significant reduction of both tumor growth and osteolysis. Simultaneous inhibition of PI3K and MEK resulted in a reduction of tumor growth, but paradoxically exhibited an exacerbation of bone damage. These findings suggest that MEK inhibition alone may be a valuable additional treatment for breast cancer osteolytic metastasis. | en_US |
dc.description.embargoterms | indefinite | en_US |
dc.identifier.citation | Bosma, N. (2013). Targeting the PI3K and Ras Signal Transduction Pathways in a Murine Model of Osteolytic Breast Cancer Metastasis (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/27979 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/27979 | |
dc.identifier.uri | http://hdl.handle.net/11023/474 | |
dc.language.iso | eng | |
dc.publisher.faculty | Graduate Studies | |
dc.publisher.faculty | Medicine | |
dc.publisher.institution | University of Calgary | en |
dc.publisher.place | Calgary | en |
dc.rights | University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | |
dc.subject | Biology--Molecular | |
dc.subject | Oncology | |
dc.subject | Biochemistry | |
dc.subject | Biology--Molecular | |
dc.subject.classification | Pre-clinical | en_US |
dc.subject.classification | Experimental | en_US |
dc.subject.classification | Oncology | en_US |
dc.title | Targeting the PI3K and Ras Signal Transduction Pathways in a Murine Model of Osteolytic Breast Cancer Metastasis | |
dc.type | master thesis | |
thesis.degree.discipline | Biochemistry and Molecular Biology | |
thesis.degree.grantor | University of Calgary | |
thesis.degree.name | Master of Science (MSc) | |
ucalgary.item.requestcopy | true |